期刊文献+

生长因子抑制剂防治后囊膜混浊的实验研究 被引量:2

Experimental study on growth factors inhibitor for preventing posterior capsule opacification
下载PDF
导出
摘要 目的 检测生长因子抑制剂苏拉明对体外原代培养的牛晶状体上皮细胞 (bovinelens epithelial cells,BL ECs)的抑制作用。方法 原代培养 BL ECs,在其生长的第 3代时分别加入含有苏拉明 0、30、10 0、2 0 0、30 0、5 0 0 mg· L- 1的 DMEM培养液 ,分别在其作用后的4h、2 d、4d、6 d用 MTT染色 -比色法检测细胞的生长情况 ;在原代培养的第 3代细胞中分别加入含 15 0 m g· L- 1 和 35 0 m g· L- 1 苏拉明的 DMEM培养液 ,分别在其作用后的 6 d和3d将细胞消化 ,进行流式细胞仪检测细胞的增殖周期。结果 浓度为 30 mg· L- 1和 30 0 mg· L- 1 的苏拉明分别作用于 BL ECs 4d或 4h,便产生了明显的抗 BL ECs增殖作用 (分别为P <0 .0 1和 P <0 .0 5 ) ,其抑制程度随作用时间的延长和试剂浓度的升高而逐渐增强。苏拉明将 BL EC阻抑于细胞增殖周期的 G2 / M期。结论 苏拉明有效抑制了体外原代培养的 BL ECs的生长 ,如进一步进行在体研究 ,可望成为防治白内障术后后囊膜混浊的一种良药。 Objective To study the preventing effect of suramin on lens epithelial cells (LECs) in vitro.Methods Bovine lens epithelial cells (BLECs) were cultured in primary manner. DMEM with six different doses of suramin (0, 30, 100, 200, 300 and 500mg·L -1 ) were added to the cultured BLECs respectively during its third growth generation. The growth of the BLECs were examined by MTT method at its four different time (4h, 2d, 4d and 6d respectively); DMEM with 350mg·L -1 and 150mg·L -1 suramin were added to cultured BLECs respectively. When the BLECs had grown for 3d and 6d, they were collected and their growth cycle was checked with lapse cytometry.Results When suramin with its doses≥30mg·L -1 and≥300mg·L -1 for 4d or 4h respectively, BLECs were inhibited significantly (P<0.01 and P<0.05 respectively). The preventing effect showed dose dependent and time dependent manner. BLECs might be blocked or head a prolonged G 2 and/or M phase in their cell cycle in suramin treated group.Conclusion Suramin can effectively inhibit BLECs' growth in vitro. If it is used in vivo, suramin will become a good drug to prevent PCO.
出处 《眼科新进展》 CAS 2001年第4期241-243,共3页 Recent Advances in Ophthalmology
关键词 生长因子 苏拉明 晶状体上皮细胞 后囊混沌 growth factor suramin bovine lens epithelial cell
  • 相关文献

参考文献10

  • 1[1]Ibaraki N, Lin LR, Reddy VN. Effects of growth factors on proliferation and differentiation in human lens epithelial cells in early subculture [J]. Invest Ophthalmol Vis Sci 1995; 36(11)∶ 2304-2312.
  • 2[2]Majima K. Human lens epithelial cells proliferate in response to exogenous EGF and have EGF receptor [J]. Ophthalmic Res 1995; 27(6)∶ 356-365.
  • 3[3]Namiki M. Quantification of basic fibroblast growth factor (bFGF) and transforming growth factor alpha (TGF alpha) in rabbit aqueous humor after intraocular lens implantation [J]. Nippon Ganka Gakkai Zasshi 1994; 98(4)∶ 334-339.
  • 4[4]Hongo M, Itoi M, Yamamura Y, et al. Distribution of epidermal growth factor receptors in rabbit lens epithelial cells [J]. Invest Ophthalmol Vis Sci 1993; 34(2)∶ 401-404.
  • 5[5]Muller WE,Wollert U.Spectroscopic studies on the co-mplex formation of suramin with bovine and human serum albumin [J]. Biochem Biophys Acta 1976; 427∶ 465-480.
  • 6[6]Braddok PS, Hu DE, Fan PD, et al. A structure-activity analysis of antagonism of the growth factor and angiogenic activity of basic fibroblast growth factorby suramin and related polyanions[J] Br J Cancer 1994; 69(5)∶ 890-898.
  • 7[7]Bemardini N,Giannessi F,Bianchi F,et al.Involvement of basic fibroblast growth factor in suramin-induced inhibition of V79/AP4 fibroblast cell proliferation [J]. Br J Cancer 1993; 67(6)∶ 1209-1216.
  • 8[8]Voogd TE, Vansterkenburg EL, Wilting J, et al. Recent research on the biological activity of suramin [J]. Pharmacol Rev 1993; 45(2)∶ 177-203.
  • 9[9]Ewing MW,Liu SC,Gnarra JR,et al.Effect of suramin on the mitogenic response of the human prostate carcinoma cell line PC-3 [J]. Cancer 1993; 71(3 Suppl)∶ 1151-1158.
  • 10[10]Van Corven EJ, Van Rijswijk A, Jalink K, et al. Mitogenic action of lysophosphatide acid and phosphatidic acid on fibroblasts [J]. Biochem J 1992; 281(Pt 1)∶ 163-169.

同被引文献31

  • 1McDonnell PJ, Stark WJ, Green WR, et al. Posterior capsule opacification: a specular microscopic study[J].Ophthalmology,1984, 91(7) :853.
  • 2Apple DJ, Solomon KD, Tetz MR, et al. Posterior capsule opacification[J]. Surv Ophthalmol, 1992,37(2):73.
  • 3Schimidbauer JM, Vargas LG, Peng Q, et al. Posterior capsule opacification [J]. Int Ophthalmol Clin, 2001,41(3): 109.
  • 4Ravalico G, Tognetto D, Palomba M, et al. Capsulorhexis size and posterior capsule opacification[J]. J Cataract Refract Surg, 1996, 22(1):98.
  • 5Hollick EJ, Spalton DJ, Ursell PG, et al. Lens epithelial cell regression on the posterior capsule with different intraocular lens materials[J]. Br J Ophthalmol, 1998,82(10):1182.
  • 6Nagata T, Watanabe I. Optic sharp edge or convexity:comparison of effects on posterior capsular opacification[J]. Jpn J Ophthalmol, 1996,40(3) :397.
  • 7Spalton DJ. Posterior capsular opacification after cataract surgery[J]. Eye, 1999,13(Pt3b) :489.
  • 8Yanada K, Nagamoto T, Yozawa H, et al. Effects of intraocular lens design on posterior capsule opacification after continuous curvilinear capsulorhexis[J]. J Cataract Refract Surg, 1995, 21(6) : 69.
  • 9Nishi O, Nishi K, Imanishi M, et al. Decreased prostaglandin E2 synthesis by lens epithelial by lens epithelial cells cultured on heparin-surface-modified poly (methyl methacrylate) [J]. J Cataract Refract Surg, 1996, 22:1859.
  • 10Philipson B, Fagerholm P, Calel B, et al . Heparin surface modified intraocular lenses. Three-month follow-up of a randomized, double-masked clinical trial[J]. J Cataract Refract surg, 1992, 18(1):71.

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部